Audits and Reviews
Lachman Consultants can assess organizations' compliance with:
  • GMP (good manufacturing practice) for intermediates, active pharmaceutical ingredients (APIs), and finished drug products
  • QSR (medical device "GMP")
  • GCP (good clinical practice)
  • GLP (good laboratory practice)
  • GPP (good promotion practice)
  • DEA (Drug Enforcement Agency)
We also have extensive experience in:
  • Performing "mock" FDA pre-approval inspections-helping to ensure that problem areas are identified and addressed before the real inspection
  • Developing drug diversion prevention and counterfeit investigation programs
  • Helping organizations ensure compliance with the Prescription Drug Marketing Act (PDMA)
  • Auditing adverse drug event (ADE) programs-from collection and evaluation through reporting and follow-up
  • Qualifying vendors
  • Performing due diligence
  • Conducting regulatory audits
  • Auditing documentation, including application integrity audits
  • Verifying activities of the regulatory committee

Back to FDA-Related Services